TARGETING HER2-ACTIVATING MUTATIONS IN ER-POSITIVE, METASTATIC BREAST CANCER

$3,617,467FY2018Defense Health AgencyDOD

Washington University, The

Investigators

TARGETING HER2-ACTIVATING MUTATIONS IN ER-POSITIVE, METASTATIC BREAST CANCER · GrantIndex